“…The majority of included studies were prospective 37,40,43,[45][46][47]50,52,56,59,60,68,69,71,73,76,77,[79][80][81] (n = 1239, 32.3%) or retrospective 13,38,39,41,42,44,48,49,51,[53][54][55]57,58,[61][62][63][64][65][66][67]70,72,74,75,78,82,83 (n = 2301, 60.1%) non-randomized studies. In particular, 12 prospective (n = 349, 9.1%) and seven retrospective (n = 378, 9.9%) single-arm studies were included, while 22 retrospective case-control (n = 1923, 50.2%) and eight prospective non-randomized studies (n = 890, 23.2%) fulfilled the abovementioned eligibility criteria.…”